The Role of TEG and ROTEM in Damage Control Resuscitation
- PMID: 33769424
- PMCID: PMC8601668
- DOI: 10.1097/SHK.0000000000001686
The Role of TEG and ROTEM in Damage Control Resuscitation
Abstract
Trauma-induced coagulopathy is associated with very high mortality, and hemorrhage remains the leading preventable cause of death after injury. Directed methods to combat coagulopathy and attain hemostasis are needed. The available literature regarding viscoelastic testing, including thrombelastography (TEG) and rotational thromboelastometry (ROTEM), was reviewed to provide clinically relevant guidance for emergency resuscitation. These tests predict massive transfusion and developing coagulopathy earlier than conventional coagulation testing, within 15 min using rapid testing. They can guide resuscitation after trauma, as well. TEG and ROTEM direct early transfusion of fresh frozen plasma when clinical gestalt has not activated a massive transfusion protocol. Reaction time and clotting time via these tests can also detect clinically significant levels of direct oral anticoagulants. Slowed clot kinetics suggest the need for transfusion of fibrinogen via concentrates or cryoprecipitate. Lowered clot strength can be corrected with platelets and fibrinogen. Finally, viscoelastic tests identify fibrinolysis, a finding associated with significantly increased mortality yet one that no conventional coagulation test can reliably detect. Using these parameters, guided resuscitation begins within minutes of a patient's arrival. A growing body of evidence suggests this approach may improve survival while reducing volumes of blood products transfused.
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Shock Society.
Conflict of interest statement
Dr BAC is on the Scientific Advisory Council for Haemonetics Corporation. There are no other relevant financial relationships or any sources of support in the form of grants, equipment, or drugs. For Dr JBB, no conflicts, actual or potential, are declared. The views expressed in this presentation are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the US Government.
Dr.Cotton has served as a conultant for Haemonetics Corp (Braintree, MA), the makers of TEG. The remaining authors have no conflicts to disclose.
Figures
References
-
- Geeraedts L, Jr, Kaasjager H, Van Vugt A, Frölke J. Exsanguination in trauma: a review of diagnostics and treatment options. Injury 40 (1):11–20, 2009. - PubMed
-
- Neuman TS, Bockman MA, Moody P, Dunford JV, Griffith LD, Guber SL, Guss DA, Baxt WG. An autopsy study of traumatic deaths; San Diego County, 1979. Am J Surg 144 (6):722–727, 1982. - PubMed
-
- Wright CS, McMurtry RY, Hoyle M, Pickard J. Preventable deaths in multiple trauma: review of deaths at Sunnybrook Medical Centre Trauma Unit. Can J Surg 26 (1):20–23, 1983. - PubMed
-
- Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT. Epidemiology of trauma deaths: a reassessment. J Trauma 38 (2):185–193, 1995. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
